Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis

Xiaojie Yuan, Jiping Wang, Shuo Yang, Mei Gao, Lingxia Cao, Xumei Li, Dongxu Hong, Suyan Tian, Chenglin Sun, Xiaojie Yuan, Jiping Wang, Shuo Yang, Mei Gao, Lingxia Cao, Xumei Li, Dongxu Hong, Suyan Tian, Chenglin Sun

Abstract

Background: At present, the beneficial effect of the ketogenic diet (KD) on weight loss in obese patients is generally recognized. However, a systematic research on the role of KD in the improvement of glycemic and lipid metabolism of patients with diabetes is still found scarce.

Methods: This meta-study employed the meta-analysis model of random effects or of fixed effects to analyze the average difference before and after KD and the corresponding 95% CI, thereby evaluating the effect of KD on T2DM.

Results: After KD intervention, in terms of glycemic control, the level of fasting blood glucose decreased by 1.29 mmol/L (95% CI: -1.78 to -0.79) on average, and glycated hemoglobin A1c by 1.07 (95% CI: -1.37 to -0.78). As for lipid metabolism, triglyceride was decreased by 0.72 (95% CI: -1.01 to -0.43) on average, total cholesterol by 0.33 (95% CI: -0.66 to -0.01), and low-density lipoprotein by 0.05 (95% CI: -0.25 to -0.15); yet, high-density lipoprotein increased by 0.14 (95% CI: 0.03-0.25). In addition, patients' weight decreased by 8.66 (95% CI: -11.40 to -5.92), waist circumference by 9.17 (95% CI: -10.67 to -7.66), and BMI by 3.13 (95% CI: -3.31 to -2.95).

Conclusion: KD not only has a therapeutic effect on glycemic and lipid control among patients with T2DM but also significantly contributes to their weight loss.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1. PRISM diagram for the systematic…
Fig. 1. PRISM diagram for the systematic review.
Only studies published in English were considered, which were identified by searching the PubMed and MEDLINE databases. The keywords used for this literature search are T2DM or diabetes mellitus, ketogenic diet, obesity, and human. The search was finished on September 20, 2019.
Fig. 2. Forest plots for blood glucose…
Fig. 2. Forest plots for blood glucose and HbA1c.
The reduced proportion of HbA1c is more significant after the KD implementation, which is regarded as the ideal therapeutic effect of drugs that is possible to be achieved on HbA1c.
Fig. 3. Forest plots for TC, TG,…
Fig. 3. Forest plots for TC, TG, LDL, and HDL.
It can be seen that after KD consumption, TG, TC, and LDL decreased. On the other hand, HDL increased.
Fig. 4. Forest plots for body weight,…
Fig. 4. Forest plots for body weight, waist circumference, and BMI.
Many studies have demonstrated that KD has a positive effect by providing effective control over obesity; our findings were consistent with the previous reports.

References

    1. Guariguata L, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pr. 2014;103:139–149.
    1. Yu Z, et al. Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in T2DM: a systematic review and metaanalysis of randomized controlled trials. Clin. Nutr. 2020;39:1724–1734. doi: 10.1016/j.clnu.2019.08.008.
    1. Guh DP, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. doi: 10.1186/1471-2458-9-88.
    1. Hussain TA, et al. Effect of low-calorie versus low-carbohydrate ketogenic diet in T2DM. Nutrition. 2012;28:1061–1021. doi: 10.1016/j.nut.2012.01.016.
    1. Hall KD, et al. Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men. Am. J. Clin. Nutr. 2016;104:324–333. doi: 10.3945/ajcn.116.133561.
    1. Hamdy O, et al. Fat versus carbohydrate-based energy-restricted diets for weight loss in patients with T2DM. Curr. Diab. Rep. 2018;18:128. doi: 10.1007/s11892-018-1103-4.
    1. Joshi S, Ostfeld RJ, McMacken M. The ketogenic diet for obesity and diabetes-enthusiasm outpaces evidence. JAMA Intern. Med. 2019;179:1163–1164. doi: 10.1001/jamainternmed.2019.2633.
    1. Saslow LR, et al. An online intervention comparing a very low-carbohydrate ketogenic diet and lifestyle recommendations versus a plate method diet in overweight individuals with T2DM: a randomized controlled trial. J. Med. Internet Res. 2017;19:e36. doi: 10.2196/jmir.5806.
    1. Saslow LR, et al. Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with T2DM mellitus or prediabetes. Nutr. Diabetes. 2017;7:304. doi: 10.1038/s41387-017-0006-9.
    1. Meng Y, et al. Efficacy of low carbohydrate diet for T2DM mellitus management: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res. Clin. Pr. 2017;131:124–131. doi: 10.1016/j.diabres.2017.07.006.
    1. Castellana M, et al. Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: a systematic review and meta-analysis. Rev. Endocr. Metab. Disord. 2019;21:5–16. doi: 10.1007/s11154-019-09514-y.
    1. Westman EC, Yancy WS, Jr., Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in T2DM mellitus. Nutr. Metab. 2008;5:36. doi: 10.1186/1743-7075-5-36.
    1. Partsalaki I, Karvela A, Spiliotis BE. Metabolic impact of a ketogenic diet compared to a hypocaloric diet in obese children and adolescents. J. Pediatr. Endocrinol. Metab. 2012;25:697–704. doi: 10.1515/jpem-2012-0131.
    1. Leonetti F, et al. Very low-carbohydrate ketogenic diet before bariatric surgery: prospective evaluation of a sequential diet. Obes. Surg. 2015;25:64–71. doi: 10.1007/s11695-014-1348-1.
    1. Walton CM, Perry K, Hart RH, Berry SL, Bikman BT. Improvement in glycemic and lipid profiles in type 2 diabetics with a 90-day ketogenic diet. J. Diabetes Res. 2019;14:8681959.
    1. Leow ZZX, Guelfi KJ, Davis EA, Jones TW, Fournier PA. The glycaemic benefits of a very-low-carbohydrate ketogenic diet in adults with Type 1 diabetes mellitus may be opposed by increased hypoglycaemia risk and dyslipidaemia. Diabet. Med. 2018;35:9. doi: 10.1111/dme.13663.
    1. Azevedo DLP, et al. Effect of classic ketogenic diet treatment on lipoprotein subfractions in children and adolescents with refractory epilepsy. Nutrition. 2017;33:271–277. doi: 10.1016/j.nut.2016.06.016.
    1. Krebs JD, et al. Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with T2DM. J. Am. Coll. Nutr. 2013;32:11–17. doi: 10.1080/07315724.2013.767630.
    1. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann. Intern. Med. 1997;127:820–826. doi: 10.7326/0003-4819-127-9-199711010-00008.
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002;21:1539–1558. doi: 10.1002/sim.1186.
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin. Trials. 1986;7:177–188. doi: 10.1016/0197-2456(86)90046-2.
    1. McKenzie, A. L. et al. A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes. JMIR Diabetes2, e5 (2017).
    1. Yancy, W. S. et al. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr. Metab. (Lond)2, 34 (2005).
    1. Athinarayanan SJ, et al. Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of T2DM: a 2-year non-randomized clinical trial. Front. Endocrinol. 2019;10:348. doi: 10.3389/fendo.2019.00348.
    1. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab. Res. Rev. 1999;15:412–426. doi: 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>;2-8.
    1. Gershuni VM, Yan SL, Medici V. Nutritional ketosis for weight management and reversal of metabolic syndrome. Curr. Nutr. Rep. 2018;7:97–106. doi: 10.1007/s13668-018-0235-0.
    1. Yancy WS, Vernon MC, Westman EC. A pilot trial of a low-carbohydrate, ketogenic diet in patients with T2DM. Metab. Syndr. Relat. Disord. 2003;1:239–243. doi: 10.1089/154041903322716723.
    1. Bolla AM, Caretto A, Laurenzi A, Scavini M, Piemonti L. Low-carb and ketogenic diets in type 1 and type 2 diabetes. Nutrients. 2019;26:962. doi: 10.3390/nu11050962.
    1. Dashti, H. M. et al. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol. Cell Biochem. 302, 249–256 (2007).
    1. Yancy, W. S. Jr. et al. A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss. Arch. Intern. Med. 170, 136–145 (2010).
    1. Stratton, I. M. et al. Association of glycaemia with macrovascular and microvascular complications of T2DM (UKPDS 35): prospective observational study. BMJ321, 405–412 (2000).
    1. Nakanishi, S. et al. Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: a retrospective longitudinal study using outpatient clinical data in Japanese patients with T2DM mellitus. Diabetes Res. Clin. Pr. 155, 107807 (2019).
    1. Dehghan, P. & Abbasalizad, F. M. Dietary acid load, blood pressure, fasting blood sugar and biomarkers of insulin resistance among adults: findings from an updated systematic review and meta-analysis. Int. J. Clin. Pr.74, 4 (2019).
    1. Avtanski, D., Pavlov, V. A., Tracey, K. J. & Poretsky, L. Characterization of inflammation and insulin resistance in high-fat diet-induced male C57BL/6J mouse model of obesity. Anim. Model Exp. Med. 2, 252–258 (2019).
    1. Saslow, L. R. et al. A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes. PLoS One9, e91027 (2014).
    1. Stocker, R. K., Reber, A. E., Bally, L., Nuoffer, J. M. & Stanga, Z. Ketogenic diet and its evidence-based therapeutic implementation in endocrine diseases. Praxis108, 541–553 (2019).
    1. Handley, R. T., Bentley, R. E., Brown, T. L. & Annan, A. A. Successful treatment of obesity and insulin resistance via ketogenic diet status post Roux-en-Y. BMJ Case Rep.2018, bcr2018225643 (2018).
    1. Tay, J. et al. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial. Am. J. Clin. Nutr. 102, 780–790 (2015).
    1. Kinzig, K. P., Honors, M. A. & Hargrave, S. L. Insulin sensitivity and glucose tolerance are altered by maintenance on a ketogenic diet. Endocrinology151, 3105–3114 (2010).
    1. Cox, N., Gibas, S., Salisbury, M., Gomer, J. & Gibas, K. Ketogenic diets potentially reverse Type II diabetes and ameliorate clinical depression: a case study. Diabetes Metab. Syndr. 13, 1475–1479 (2019).
    1. Goday, A. et al. Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr Diabetes6, e230 (2016).
    1. Cohen, C. W. et al. A ketogenic diet reduces central obesity and serum Insulin in women with ovarian or endometrial cancer. J. Nutr. 148, 1253–1260 (2018).
    1. Myette-Cote, E. et al. The effect of a short-term low-carbohydrate, high-fat diet with or without postmeal walks on glycemic control and inflammation in type 2 diabetes: a randomized trial. Am. J. Physiol. Regul. Integr. Comp. Physiol.315, R1210–R1219 (2018).
    1. Zhu, B. et al. Lipid oversupply induces CD36 sarcolemmal translocation via dual modulation of PKCzeta and TBC1D1: an early event prior to insulin resistance. Theranostics10, 1332–1354 (2020).
    1. Akhtar, D. H., Iqbal, U., Vazquez-Montesino, L. M., Dennis, B. B. & Ahmed, A. Pathogenesis of insulin resistance and atherogenic dyslipidemia in nonalcoholic fatty liver disease. J. Clin. Transl. Hepatol.7, 362–370 (2019).
    1. Iqbal, J., Al Qarni, A., Hawwari, A., Alghanem, A. F. & Ahmed, G. Metabolic syndrome, dyslipidemia and regulation of lipoprotein metabolism. Curr. Diabetes Rev. 14, 427–433 (2018).
    1. Laakso, M. & Kuusisto, J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat. Rev. Endocrinol. 10, 293–302 (2014).
    1. Han, L. et al. Free fatty acid can induce cardiac dysfunction and alter insulin signaling pathways in the heart. Lipids Health Dis.17, 185 (2018).
    1. Yu, S. et al. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats. Stem Cell Res. Ther. 10, 333 (2019).
    1. Ponce, A. J. et al. Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans. Endocrine67, 331–343 (2020).
    1. Karasek, D. & Vaverkova, H. Diabetic dyslipidemia and microvascular complications of diabetes. Vnitr. Lek.64, 17–24 (2018).
    1. Sajoux, I. et al. Effect of a very-low-calorie ketogenic diet on circulating myokine levels compared with the effect of bariatric surgery or a low-calorie diet in patients with obesity. Nutrients11, 2368 (2019).

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel